Toggle navigation
Home
Search
Services
Blog
Contact
About
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Protein folding in the cell: Challenges and coping mechanisms
Analysis of Racial Disparities in HCC by Systems Metabolomics
Pneumococcal immunization through a novel mechanism
Diversity in Biomedical Careers via a BioScience Sharium
Picornaviral Processing Proteinases
Recently added grants:
Biasing the Forgetting of Visual Memories
Intracellular Signaling by Bacterial Chemoreceptors
UNC Initiative for Maximizing Student Development
The UNC Chapel Hill Superfund Research Program (UNC-SRP)
The University of Iowa IMSD: Iowa Biosciences Academy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095129-004
Application #
6828932
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2003
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
NIH 2002
N01 CA
A Randomized Controlled Phase II Clinical Trial of Modulation of Inter-261995129
/ Johns Hopkins University
Comments
Be the first to comment on this grant